Medizen Humancare Inc Co., Ltd Logo

Medizen Humancare Inc Co., Ltd

A research company specializing in genomic analysis for personalized healthcare.

236340 | KO

Overview

Corporate Details

ISIN(s):
KR7236340006
LEI:
Country:
South Korea
Address:
서울특별시 송파구 정의로7길 6 PNS홈즈타워 6층, 서울특별시

Description

Medizen Humancare Inc Co., Ltd. is a research company specializing in genomic analysis for personalized healthcare. The company develops and provides services for medical and pharmacological research, genomic analysis, and disease forecasting. Its core offerings involve analyzing an individual's genetic information to predict the risk of various diseases, enabling customized health management and treatment plans. By leveraging a substantial volume of genomic big data, the company aims to advance the paradigm of precision medicine and contribute to a ubiquitous healthcare environment through personalized solutions based on an individual's unique genetic makeup.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-05-13 00:00
기업설명회(IR)개최결과
Korean HTML 6.7 KB
2025-04-28 00:00
기업설명회(IR)개최
Korean HTML 7.1 KB
2025-03-31 00:00
정기주주총회결과
Korean HTML 16.2 KB
2025-03-21 00:00
사업보고서 (2024.12)
Korean HTML 1.1 MB
2025-03-21 00:00
감사보고서제출
Korean HTML 10.4 KB
2025-03-14 00:00
주주총회소집공고
Korean HTML 143.7 KB
2025-02-24 00:00
주주총회소집결의
Korean HTML 6.8 KB
2024-12-31 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 31.5 KB
2024-12-23 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 71.6 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.1 KB
2024-11-04 00:00
기업설명회(IR)개최결과
Korean HTML 6.7 KB
2024-10-21 00:00
기업설명회(IR)개최
Korean HTML 7.1 KB
2024-08-29 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 79.2 KB
2024-06-26 00:00
타법인주식및출자증권취득결정
Korean HTML 13.7 KB
2024-06-26 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 35.4 KB

Automate Your Workflow. Get a real-time feed of all Medizen Humancare Inc Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medizen Humancare Inc Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medizen Humancare Inc Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.